|1.||Thakur, Sunitha B: 1 article (06/2007)|
|2.||Koutcher, Jason A: 1 article (06/2007)|
|3.||Koziorowski, Jacek: 1 article (06/2007)|
|4.||Ling, C Clifton: 1 article (06/2007)|
|5.||Claus, Filip: 1 article (06/2007)|
|6.||Burgman, Paul: 1 article (06/2007)|
|7.||Matei, Cornelia: 1 article (06/2007)|
|8.||Procissi, Daniel: 1 article (06/2007)|
|9.||Chapman, J Donald: 1 article (06/2007)|
06/15/2007 - "The feasibility of obtaining TF-MISO tumor distribution maps in a reasonable time frame was established. "
06/15/2007 - "Late time point (>6 h) tumor tissue concentrations, as obtained from (19)F MRS, suggest that TF-MISO is reduced and retained in hypoxic tumor. "
04/01/1992 - "Photobiological studies were performed with EMT-6 tumor cells in vitro utilizing Photofrin II (PII) in combination with etanidazole (ETAN), misonidazole (MISO), and trifluoromisonidazole (TF-MISO). "
06/15/2007 - "2-Nitro-alpha-[(2,2,2-trifluoroethoxy)methyl]-imidazole-1-ethanol (TF-MISO) was investigated as a potential noninvasive marker of tissue oxygen levels in tumors using (19)F magnetic resonance spectroscopy (MRS) and (19)F chemical shift imaging. "
|2.||Dihematoporphyrin Ether (Porfimer Sodium)
|5.||Ethanol (Ethyl Alcohol)